Drugs for Treatment of Ear, Eye, Nose, and Throat Problems Flashcards
Allergic Rhinitis Drugs delivered locally as nasal spray
Drugs delivered locally as nasal spray
- Antihistamines
- Antimuscarinics
- Cromolyn compounds
- Topical corticosteroids
- Nasal decongestants
- Sympathomimetic Agents
- alpha-adrenergic agonists
Antihistamine Action

Antihistamines:
H1 Receptor Antagonists
Several structural classes
Pharmacokinetics
- rapidly absorbed
- large Vd
- 2nd generation drugs do not cross BBB
- metabolized in the liver
- t1/2 most drugs = 4-6 hours
- sustained release preparations t1/2= 12-24 hrs
Histamine H1 antagonists

Histamine H1 - Receptor Blockers

Clinical Indications 1
- Acute and Chronic Allergic Rhinitis
- Vasomotor rhinitis
- antimuscarinic effects help
- Eosinophilic nonallergic rhinitis
- Viral Upper Respiratory Infection
- antimuscarinic effects help
Clinical Indications 2
- Urticaria
- Allergic conjunctivitis
- Anaphylactic reactions
- adjunct to epinephrine
- Motion sickness and nausea
- Insomnia
Key Drugs - 1st Generation
- Diphenhydramine (Benadryl)
- Chlorpheniramine (Chlor-Trimeton)
- Others
- Dimenhydrinate (Dramamine)
- Cyclizine (Marezine)
- Hydroxyzine (Atarax)
- Meclizine (Bonine)
- Promethazine (Phenergan)
Key Drugs - 2nd generation
- Cetirizine (Zyrtec)
- $63.29 (2003 price for 30 day supply)
- Fexofenadine (Allegra)
- $84.62
- Loratadine (generic, Claritin, Alavert)
- $21.30, $27.30, $16.50
- Desloratadine (Clarinex)
- $69.74
- Azelastine (Astelin) Intranasal spray
- $71.48
Key Points - 2nd generation
- Less complete distribution to CNS
- little drug crosses BBB –therefore, much less sedation compared to 1st generation drugs
- Have longer elimination t1/2 than 1st generation
- therefore, longer duration of action
- Lower incidence of antimuscarinic side effects, e.g. dry mouth, dysuria, etc.
Clinical Effects
- All antihistamines are effective for relieving:
- sneezing
- nasal itching
- nasal discharge (rhinorrhea)
- Not very effective for relieving:
- congestion
- add decongestant
Side Effects 1
- 1st generation agents
- sleepiness
- interfere with learning
- decrease work productivity
- impair psychomotor performance
- increases risk of injury
- Patient may be unaware of these effects
- Side effects may persist morning after taking drug at bedtime
Side Effects 2
- Sedation - antimuscarinic effect
- 1st generation only
- CNS
- dizziness, tinnitus, nervousness, insomnia, fatigue, blurred vision
- 1st generation only
- GI
- nausea, vomiting, loss of appetite
- Dry mouth – (antimuscarinic effect)
- 1st generation only
- Urinary retention –
- (antimuscarinic effect) 1st generation only
Decongestants
- alpha-adrenergic agonists
- cause vasoconstriction, reduce edema
- available as nasal spray or oral tablets
- Pseudoephedrine
- prescription, or behind the counter restrictions
- Phenylephrine
- Naphazoline
- Oxymetazoline
- Tetrahydrozoline
- Xylometazoline
- Pseudoephedrine
Decongestants
alpha-adrenergic agonists
- alpha-adrenergic agonists
- Effective only for relief of nasal congestion and not sneezing, itching, or discharge
- Often given in combination with an H1-antihistamine
- Adverse effects include insomnia, excitability, headache, nervousness, palpitations, tachycardia, arrhythmia, hypertension, nausea, vomiting, and urinary retention.
- Should not be used more than 3 days in order to avoid rebound congestion and rhinitis medicamentosa
Antitussives
- Opioids: central suppression of cough reflex
- Codeine
- Dextromethorphan
- Non-opioids:
- Benoxinate - local anesthetic
- Diphenhydramine - antihistamine
Expectorants
- Facilitate secretion or decrease viscosity of mucus to facilitate clearance of mucus secretions in airways.
- N-acetyl-cysteine breaks sulfhydryl bonds in mucus proteins; makes mucus less sticky
- Guaifenesin: claimed to facilitate removal of viscous mucus.
- Potassium iodide: claimed to decrease viscosity of mucus.
- Recombinant DNAse (Dornase alpha)
- useful in cystic fibrosis.
Other Therapy for Rhinitis
- Ipratropium bromide
- vasomotor rhinitis
- Intranasal cromolyn sodium, nedocromil
- Intranasal corticosteroids
- beclomethasone dipropionate
- budesonide
- flunisolide
- fluticasone propionate
- triamcinolone acetonide
Antimuscarinics:
Ipratropium bromide
-
A quaternary muscarinic receptor antagonist
- If given parenterally, effects are like atropine
- But, only given as inhaled aerosol to treat COPD
- few side effects, even when swallowed because is poorly absorbed from GI and does not cross into brain
- quaternary amine- poor diffusion across membranes
- Parasympathetic - mediated bronchospasm is a significant component of airway resistance in some asthmatics and COPD patients, especially psychogenic exacerbations
Ipratropium bromide
Therapeutic Use:
- Therapeutic Use:
- Bronchodilation develops more slowly and is usually less intense than that produced by b-agonists.
- Useful bronchodilation lasts up to 6 hours.
- Principal use of ipratropium is in COPD.
- Combined with albuterol = COMBIVENT
- Also used intranasally (Roxane) to reduce secretions in the upper and lower respiratory tract in allergic rhinitis and chronic postnasal drip syndrome.
Cromolyn Compounds
- Cromolyn sodium nasal spray (Nasalcrom)
- Cromolyn sodium (Intal)
Antihistamines Partially Block

Cromolyn Compounds
MOA
- Cromolyn compounds are anti-inflammatory agents that indirectly inhibit antigen-induced bronchospasm and directly inhibit the release of histamine and other autocoids from sensitized mast cells.
- May suppress the activating effects of chemoattractant peptides on eosinophils, neutrophils, and monocytes.
Cromolyn Compounds:
Therapeutic Use
- Cromolyn compounds do not directly relax smooth muscle, therefore they are not useful for control of acute bronchospasm.
- Cromolyn compounds are primarily prophylactic. When inhaled several times daily, they inhibit both the immediate and late asthmatic responses to antigenic challenge or exercise.





